Abstract
Metal ions are indispensable for sustaining normal cellular functions and preserving tissue integrity, as they participate in enzymatic catalysis, signal transduction, and antioxidant defense. However, dysregulation of metal ion homeostasis, particularly during aging, disrupts cellular balance and significantly drives the development and progression of age-related ocular diseases, including age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts. Specifically, metal ions modulate key stress responses that are central to aging and ocular pathogenesis. Excessive accumulation of redox-active metals triggers the generation of reactive oxygen species that induce oxidative damage to lipids, proteins, and DNA. Meanwhile, deficiencies in essential metals, such as iron, zinc, copper, and calcium, impair antioxidant enzyme activity and disrupt DNA repair, exacerbating cellular dysfunction and senescence. The therapeutic potential of these metal chelators and antioxidants in restoring their balance, alleviating oxidative stress, and slowing the progression of age-related ocular diseases has been well documented. A deeper understanding of how metal ions influence these processes is crucial for developing more targeted and effective treatments. This article systematically reviews the roles of metal ions in age-related ocular diseases, with a focus on their effects on stress responses and potential therapeutic strategies.
Similar content being viewed by others
Acknowledgements
This study was funded by National Natural Science Foundation of China [82501266, 82471074], Guangdong Basic and Applied Basic Research Foundation [2026A1515012390, 2024A1515013058], the Science and Technology Program of Guangzhou, China [202206080005], China National Postdoctoral Program for Innovative Talents [BX20240440], China Postdoctoral Science Foundation [2025M772142], Clinical Research Incubation Project, West China Hospital, Sichuan University [2021HXFH026], Aier Ophthalmology-Sichuan University Scientific Research Fund Project [23JZH039], Sichuan Provincial Natural Science Foundation General Project [2026NSFSC0556], and the Research Funds of the State Key Laboratory of Ophthalmology [2025QNJS18].
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zhang, C., Wu, J., Shen, X. et al. Metal ions in aging and ocular diseases: biology, pathophysiology, and therapeutic strategies. npj Aging (2026). https://doi.org/10.1038/s41514-026-00396-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41514-026-00396-4
